Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2020
Home
2020
August 31, 2020
Published by
Dominic Burg
on
August 31, 2020
Categories
FY20 Results Presentation
July 28, 2020
Published by
Tiffany McMillan
on
July 28, 2020
Categories
Cellmid signed exclusive agreement with premium salon distributor in the USA
July 22, 2020
Published by
Tiffany McMillan
on
July 22, 2020
Categories
Cellmid Appendix 4C-Q4 FY2020 Business Activity
July 9, 2020
Published by
Tiffany McMillan
on
July 9, 2020
Categories
ASX Aware query
July 9, 2020
Published by
Tiffany McMillan
on
July 9, 2020
Categories
Cellmid signs exclusive agreement for SARS-CoV-2 laboratory tests
July 7, 2020
Published by
Tiffany McMillan
on
July 7, 2020
Categories
Market release – Pause in trading
July 6, 2020
Published by
Tiffany McMillan
on
July 6, 2020
Categories
Extension of Wondfo Sars-coV-2 rapid test distribution agreement
June 23, 2020
Published by
Tiffany McMillan
on
June 23, 2020
Categories
Appendix 3Y – Change of Director’s Interest Notice
June 18, 2020
Published by
Tiffany McMillan
on
June 18, 2020
Categories
Form 604 – Notice of change of interests of substantial holder
Prev page
1
2
3
4
5
6
7
8
9
Next page
